Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) EBT (2016 - 2025)

Bio Key International's EBT history spans 16 years, with the latest figure at -$964849.0 for Q3 2025.

  • For Q3 2025, EBT fell 30.57% year-over-year to -$964849.0; the TTM value through Sep 2025 reached -$4.3 million, up 23.17%, while the annual FY2024 figure was -$4.3 million, 50.05% up from the prior year.
  • EBT for Q3 2025 was -$964849.0 at Bio Key International, up from -$1.2 million in the prior quarter.
  • Across five years, EBT topped out at -$48336.0 in Q2 2021 and bottomed at -$5.0 million in Q4 2022.
  • The 5-year median for EBT is -$1.4 million (2024), against an average of -$1.6 million.
  • The largest annual shift saw EBT surged 93.49% in 2021 before it plummeted 3456.27% in 2022.
  • A 5-year view of EBT shows it stood at -$2.0 million in 2021, then tumbled by 148.04% to -$5.0 million in 2022, then skyrocketed by 47.04% to -$2.6 million in 2023, then surged by 46.88% to -$1.4 million in 2024, then skyrocketed by 31.45% to -$964849.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's EBT are -$964849.0 (Q3 2025), -$1.2 million (Q2 2025), and -$736545.0 (Q1 2025).